These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 14681296

  • 1. Developmentally regulated functions of the H19 differentially methylated domain.
    Vernucci M, Cerrato F, Pedone PV, Dandolo L, Bruni CB, Riccio A.
    Hum Mol Genet; 2004 Feb 01; 13(3):353-61. PubMed ID: 14681296
    [Abstract] [Full Text] [Related]

  • 2. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19.
    Constância M, Dean W, Lopes S, Moore T, Kelsey G, Reik W.
    Nat Genet; 2000 Oct 01; 26(2):203-6. PubMed ID: 11017078
    [Abstract] [Full Text] [Related]

  • 3. Regulatory mechanisms at the mouse Igf2/H19 locus.
    Kaffer CR, Grinberg A, Pfeifer K.
    Mol Cell Biol; 2001 Dec 01; 21(23):8189-96. PubMed ID: 11689707
    [Abstract] [Full Text] [Related]

  • 4. Developmental profile of H19 differentially methylated domain (DMD) deletion alleles reveals multiple roles of the DMD in regulating allelic expression and DNA methylation at the imprinted H19/Igf2 locus.
    Thorvaldsen JL, Fedoriw AM, Nguyen S, Bartolomei MS.
    Mol Cell Biol; 2006 Feb 01; 26(4):1245-58. PubMed ID: 16449639
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
    Yang Y, Hu JF, Ulaner GA, Li T, Yao X, Vu TH, Hoffman AR.
    J Cell Biochem; 2003 Dec 01; 90(5):1038-55. PubMed ID: 14624463
    [Abstract] [Full Text] [Related]

  • 6. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.
    Vernucci M, Cerrato F, Besnard N, Casola S, Pedone PV, Bruni CB, Riccio A.
    Oncogene; 2000 Dec 14; 19(54):6376-85. PubMed ID: 11175353
    [Abstract] [Full Text] [Related]

  • 7. An enhancer element at the Igf2/H19 locus drives gene expression in both imprinted and non-imprinted tissues.
    Charalambous M, Menheniott TR, Bennett WR, Kelly SM, Dell G, Dandolo L, Ward A.
    Dev Biol; 2004 Jul 15; 271(2):488-97. PubMed ID: 15223349
    [Abstract] [Full Text] [Related]

  • 8. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stéhelin D, Coll J, Riou G.
    Oncogene; 1996 Jan 18; 12(2):423-30. PubMed ID: 8570220
    [Abstract] [Full Text] [Related]

  • 9. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
    Vu TH, Li T, Nguyen D, Nguyen BT, Yao XM, Hu JF, Hoffman AR.
    Genomics; 2000 Mar 01; 64(2):132-43. PubMed ID: 10729220
    [Abstract] [Full Text] [Related]

  • 10. CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus.
    Engel N, Thorvaldsen JL, Bartolomei MS.
    Hum Mol Genet; 2006 Oct 01; 15(19):2945-54. PubMed ID: 16928784
    [Abstract] [Full Text] [Related]

  • 11. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
    Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM.
    Nature; 2000 May 25; 405(6785):486-9. PubMed ID: 10839547
    [Abstract] [Full Text] [Related]

  • 12. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.
    Bell AC, Felsenfeld G.
    Nature; 2000 May 25; 405(6785):482-5. PubMed ID: 10839546
    [Abstract] [Full Text] [Related]

  • 13. The 3' portion of the mouse H19 Imprinting-Control Region is required for proper tissue-specific expression of the Igf2 gene.
    Hagège H, Nasser R, Weber M, Milligan L, Aptel N, Jacquet C, Drewell RA, Dandolo L, Surani MA, Cathala G, Forné T.
    Cytogenet Genome Res; 2006 May 25; 113(1-4):230-7. PubMed ID: 16575185
    [Abstract] [Full Text] [Related]

  • 14. Deletions and rearrangements of the H19/IGF2 enhancer region in patients with Silver-Russell syndrome and growth retardation.
    Grønskov K, Poole RL, Hahnemann JM, Thomson J, Tümer Z, Brøndum-Nielsen K, Murphy R, Ravn K, Melchior L, Dedic A, Dolmer B, Temple IK, Boonen SE, Mackay DJ.
    J Med Genet; 2011 May 25; 48(5):308-11. PubMed ID: 21278389
    [Abstract] [Full Text] [Related]

  • 15. H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19.
    Srivastava M, Hsieh S, Grinberg A, Williams-Simons L, Huang SP, Pfeifer K.
    Genes Dev; 2000 May 15; 14(10):1186-95. PubMed ID: 10817754
    [Abstract] [Full Text] [Related]

  • 16. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
    Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, Chen HL, Hu JF, Behr B, Giudice L, Hoffman AR.
    Mol Hum Reprod; 2005 Sep 15; 11(9):631-40. PubMed ID: 16219628
    [Abstract] [Full Text] [Related]

  • 17. Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations.
    Engel N, West AG, Felsenfeld G, Bartolomei MS.
    Nat Genet; 2004 Aug 15; 36(8):883-8. PubMed ID: 15273688
    [Abstract] [Full Text] [Related]

  • 18. A complex duplication created by gene targeting at the imprinted H19 locus results in two classes of methylation and correlated Igf2 expression phenotypes.
    Reed MR, Huang CF, Riggs AD, Mann JR.
    Genomics; 2001 Jun 01; 74(2):186-96. PubMed ID: 11386755
    [Abstract] [Full Text] [Related]

  • 19. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting.
    Wojdacz TK, Dobrovic A, Algar EM.
    Hum Mutat; 2008 Oct 01; 29(10):1255-60. PubMed ID: 18473334
    [Abstract] [Full Text] [Related]

  • 20. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
    Manoharan H, Babcock K, Pitot HC.
    Mol Carcinog; 2004 Sep 01; 41(1):1-16. PubMed ID: 15352122
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.